التفاصيل البيبلوغرافية
| العنوان: |
A Model-Based Insulin Dose Optimization Algorithm for People With Type 1 Diabetes on Multiple Daily Injections Therapy. |
| المؤلفون: |
Fathi, Anas El1, Kearney, Robert E.2, Palisaitis, Emilie2, Boulet, Benoit1, Haidar, Ahmad3 ahmad.haidar@mcgill.ca |
| المصدر: |
IEEE Transactions on Biomedical Engineering. Apr2021, Vol. 68 Issue 4, p1208-1219. 12p. |
| مصطلحات موضوعية: |
*MATHEMATICAL optimization, *DECISION support systems, TYPE 1 diabetes, INSULIN, BOLUS drug administration, GLYCEMIC index |
| مستخلص: |
Objective: Multiple daily injections (MDI) therapy is the most common treatment for type 1 diabetes (T1D) including basal insulin doses to keep glucose levels constant during fasting conditions and bolus insulin doses with meals. Optimal insulin dosing is critical to achieving satisfactory glycemia but is challenging due to inter- and intra-individual variability. Here, we present a novel model-based iterative algorithm that optimizes insulin doses using previous-day glucose, insulin, and meal data. Methods: Our algorithm employs a maximum-a-posteriori method to estimate parameters of a model describing the effects of changes in basal-bolus insulin doses. Then, parameter estimates, their confidence intervals, and the goodness of fit, are combined to generate new recommendations. We assessed our algorithm in three ways. First, a clinical data set of 150 days (15 participants) were used to evaluate the proposed model and the estimation method. Second, 60-day simulations were performed to demonstrate the efficacy of the algorithm. Third, a sample 6-day clinical experiment is presented and discussed. Results: The model fitted the clinical data well with a root-mean-square-error of 1.75 mmol/L. Simulation results showed an improvement in the time in target (3.9–10 mmol/L) from 64% to 77% and a decrease in the time in hypoglycemia (< 3.9 mmol/L) from 8.1% to 3.8%. The clinical experiment demonstrated the feasibility of the algorithm. Conclusion: Our algorithm has the potential to improve glycemic control in people with T1D using MDI. Significance: This work is a step forward towards a decision support system that improves their quality of life. [ABSTRACT FROM AUTHOR] |
|
Copyright of IEEE Transactions on Biomedical Engineering is the property of IEEE and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Business Source Index |
